Sacramento, CA -- April 20, 2018 -- InvestorsHub NewsWire -- A new
report and video has been published on Innovest Global, Inc. (OTC
PINK: IVST). Innovest Global, Inc. is a diversified holding company
that focuses on acquiring niche, high-growth businesses that are
capable of generating significant annual revenue. The company’s
planned subsidiaries operate across telehealth, biotech, commercial
energy, business-to-business distribution, national call center and
auto sales.
The report provides an overview of Innovest Global, Inc., its
subsidiaries, financials, industry analysis and more. The content
also covers the global outlook for the brain tumor and LED lighting
markets.
Grand View Research: Brain Tumor Diagnostics and
Therapeutics Market Forecast to Reach $773.10 Million By
2025
Innovest Global’s primary operating divisions are across
commercial/industrial energy and biotech & health sciences.
Both divisions have deep roots in high-growth markets with long
term potential.
The brain tumor diagnostics and therapeutics market is estimated
to be worth $773.10 million by 2025, according to Grand View
Research. The market research firm sees the massive growth due to
the “increasing incidence of various brain cancers, particularly
glioblastoma.”
According to Renub Research, the global LED lighting market
is estimated to be worth $100 billion by the end of 2024. The
market research firm sees the vast global growth primarily stemming
from exponential global urbanization and greater awareness to
energy efficiency systems.
Health and energy are two key areas of the market that will
consistently see demand and growth over the long-term.
Civilizations require adequate health care and energy capabilities,
which are also constantly being updated and innovated. The
long-term suggests strength for the brain tumor treatment and LED
lighting markets, which will be highly beneficial for Innovest
Global.
Innovest Sees Q1 Revenue Beating Estimates, 50 Million
Common Shares Cancelled
On April 16th, Innovest Global released their first quarter
2018 earnings report. The company reported total revenues
greater than $708,000, gross profit of just under $330,000, and
cash on hand greater than $600,000. Furthermore, the company
reported total current assets of $932,096 and total current
liabilities of $352,165, giving Innovest Global a strong quick
ratio of 2.60, which is four times stronger than the conglomerate
industry average of 0.60.
Management announced it has also cancelled 50 million common
shares, which provides the company with the updated share
structure, as of March 31st:
- Authorized Shares: 500 Million
- Outstanding Shares: 96.52 Million
- Shares in Float: 11.80 Million
“The response we are getting from business and technology owners
that want to get to the next level is very encouraging,” said
Innovest CEO, Dan Martin. “We are incrementally increasing the size
of the organizations we are looking to acquire and seeing great
progress.”
Entering into the second quarter, Innovest Global is now
generating baseline quarterly revenues of around $800,000, just
from its Commercial & Industrial Energy division alone. This
comes as management is scheduled to officially launch its Biotech
& Health Sciences division this Spring.
Innovest Global recently announced that it has signed a Letter
of Intent to acquire a 20% stake in StemVax Therapeutics,
a biotechnology company that is currently developing a
brain cancer vaccine.
The StemVax Glioblast (SVX-GB) cancer vaccine is being designed
and formulated to help restore a patient’s immune system in order
to fight off existing cancer cells within the body. The
vaccine is designed to fight against glioblastoma brain
cancers, which is the same type of tumor that is currently
affecting Arizona Senator John McCain.
Innovest Global, Inc. was also featured on an episode
of Spotlight Growth Live, a video web series that focuses on
emerging growth companies.
For more information on Innovest Global, Inc.,
Please
visit: http://innovestglobal.com and http://spotlightgrowth.com/index.php/2018/04/19/innovest-global-inc-otc-pink-ivst-a-high-growth-cong...
SpotlightGrowth.com is a digital hub for micro-caps,
small-caps, crowdfunding, cryptocurrency, and other emerging growth
investors. SpotlightGrowth.com serves as our media
subsidiary and provides insights on small cap companies.
Disclaimer:
Spotlight Growth is compensated, either directly or via a third
party, to provide investor relations services for its
clients. Spotlight Growth creates exposure for companies
through a customized marketing strategy, including design of
promotional material, the drafting and editing of press releases
and media placement.
All information on featured companies is provided by the
companies profiled, or is available from public sources. Spotlight
Growth and its employees are not a Registered Investment Advisor,
Broker Dealer or a member of any association for other research
providers in any jurisdiction whatsoever and we are not qualified
to give financial advice. The information contained herein is based
on external sources that Spotlight Growth believes to be reliable,
but its accuracy is not guaranteed. Spotlight Growth may
create reports and content that has been compensated by a company
or third-parties, or for purposes of self-marketing. Spotlight
Growth was compensated two thousand five hundred dollars cash and
fifty thousand restricted shares for the creation and dissemination
of this content.
This material does not represent an investment solicitation.
Certain statements contained herein constitute “forward-looking
statements” within the meaning of the Private Securities Litigation
Reform Act of 1995. Such statements may include, without
limitation, statements with respect to the Company’s plans and
objectives, projections, expectations and intentions. These
forward-looking statements are based on current expectations,
estimates and projections about the Company’s industry,
management’s beliefs and certain assumptions made by
management.
The above communication, the attachments and external Internet
links provided are intended for informational purposes only and are
not to be interpreted by the recipient as a solicitation to
participate in securities offerings. Investments referenced
may not be suitable for all investors and may not be permissible in
certain jurisdictions.
Spotlight Growth and its affiliates, officers, directors, and
employees may have bought or sold or may buy or sell shares in the
companies discussed herein, which may be acquired prior, during or
after the publication of these marketing materials. Spotlight
Growth, its affiliates, officers, directors, and employees may sell
the stock of said companies at any time and may profit in the event
those shares rise in value. For more information on our
disclosures, please
visit: http://spotlightgrowth.com/index.php/disclosures/
Contact: Matt Rego 916 525 7147 mrego@spotlightgrowth.com
Innovest Global (CE) (USOTC:IVST)
Historical Stock Chart
From Oct 2024 to Nov 2024
Innovest Global (CE) (USOTC:IVST)
Historical Stock Chart
From Nov 2023 to Nov 2024
